23 Feb NanoHive Medical Announces Distribution Agreement with Accelus
Further expands distribution of NanoHive Medical’s Hive™ Soft Titanium® 3D printed interbody fusion technology.
BOSTON, Mass., February 21, 2022 – NanoHive Medical, LLC (previously HD LifeSciences), a leading innovator in 3D printed, biomimetic spinal interbody fusion solutions, today announced that it has entered into a distribution agreement with Accelus, a privately held medical technology company dedicated to advancing spinal surgery treatment options by developing and commercializing an ecosystem of enabling technologies. The agreement expands the distribution network for NanoHive Medical’s Hive™ Soft Titanium® portfolio of interbody fusion devices in the United States.
“This exciting collaboration gives surgeons access to our innovative Hive™ Soft Titanium® 3D printed interbody fusion technology along with Accelus’s innovative
product portfolio including their flagship FlareHawk® and TiHawk™ Multidirectional Expanding Interbody Fusion Devices and Remi™ Robotic Navigation System.” said Patrick O’Donnell, President & Chief Executive Officer for NanoHive Medical. “We anticipate the partnership will broaden NanoHive’s market penetration to include the significant volume of spinal fusion procedures migrating from hospital in-patient facilities to out-patient and ambulatory care surgery center facilities.”
The Hive portfolio of interbody fusion devices provides surgeons and their patients with biomechanical elastic modulus properties comparable to PEEK devices, clear and precise diagnostic imaging capability, advanced titanium surface technology which enables osteoblastic cell attraction and integration, and proprietary biologics injection ports. These features may or are designed to lead to consistently strong fusion constructs and efficacious clinical experiences.
“We are excited to enter into this relationship with NanoHive,” said Kevin McGann, President of Accelus Inc. “It provides us with a unique opportunity to quickly expand our portfolio of differentiated, best-in-class interbody fusion devices to address a full range of pathologies and spinal approaches.”
About NanoHive Medical LLC
NanoHive Medical is a pioneer and leading innovator in 3D printed spinal interbody fusion implants and instrumentation. The company’s proprietary, biomimetic Soft Titanium® technology clearly distinguishes their products in the $1.9B spinal interbody fusion device market. The Hive™ portfolio of interbody fusion devices provide surgeons and their patients ideal biomechanical elastic modulus properties, clear and precise diagnostic imaging capability, osteoblast cell attraction and integration – all features that are designed to lead to consistently strong fusion constructs and efficacious clinical experiences. NanoHive Medical is located in Woburn, Massachusetts, U.S.A. Learn more at www.NanoHive.com.
About Accelus
Integrity Implants Inc. d/b/a Accelus is committed to accelerating minimally invasive spine surgery through its enabling technology with broad accessibility to previously underserved markets. Established in 2021 through the combination of Integrity Implants and Fusion Robotics, the company is focused on providing its proprietary Adaptive Geometry technology with pragmatic and economical navigation and robotic solutions with broad clinical use in spine surgery. Learn more at www.accelusinc.com.